We are live on
!
Find out more
LP
LMR Partners Portfolio holdings
AUM
$45.4B
1-Year Est. Return
60.68%
This Fund
S&P 500
This Quarter
Est. Return
+3.34%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$10.7B
AUM Growth
-$1.2B
(-10%)
Cap. Flow
-$1.77B
Cap. Flow
% of AUM
-16.59%
Top 10 Holdings %
Top 10 Hldgs %
17.61%
Holding
1,734
New
553
Increased
270
Reduced
235
Closed
408
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$107M |
| 2 |
Seagate
STX
|
+$46.6M |
| 3 |
Roper Technologies
ROP
|
+$46.2M |
| 4 |
Intel
INTC
|
+$44.7M |
| 5 |
Nutanix
NTNX
|
+$42.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$469M |
| 2 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$204M |
| 3 |
NVIDIA
NVDA
|
+$43.7M |
| 4 |
Boeing
BA
|
+$42M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.53% |
| 2 | Financials | 5.9% |
| 3 | Healthcare | 3.32% |
| 4 | Energy | 2.62% |
| 5 | Communication Services | 2.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
PUT
Summit Therapeutics
SMMT
$10B
| $2.64M | 0.02% |
136,800
+15,000
| +12% | +$301K |
|
552
Linde
LIN
$236B
| $2.64M | 0.02% |
5,663
+2,600
| +85% | +$1.17M |
|
553
Walmart Inc
WMT
$900B
| $2.63M | 0.02% |
30,000
-92,301
| -75% | -$8.66M |
|
554
PUT
Okta
OKTA
$23.7B
| $2.63M | 0.02% |
+25,000
| New | +$2.44M |
|
555
Diageo
DEO
$49.4B
| $2.62M | 0.02% |
25,000
| – | – |
|
556
Arm
ARM
$261B
| $2.6M | 0.02% |
+24,351
| New | +$3.4M |
|
557
Intuitive Surgical
ISRG
$130B
| $2.6M | 0.02% |
5,250
+1,724
| +49% | +$953K |
|
558
Bristol-Myers Squibb
BMY
$130B
| $2.59M | 0.02% |
42,390
-89,777
| -68% | -$5.23M |
|
559
Honda
HMC
$39.3B
| $2.57M | 0.02% |
94,791
-130,209
| -58% | -$3.71M |
|
560
CALL
SLB Ltd
SLB
$74.2B
| $2.57M | 0.02% |
61,400
+11,400
| +23% | +$467K |
|
561
CALL
Moderna
MRNA
$22.1B
| $2.56M | 0.02% |
90,200
+69,200
| +330% | +$2.46M |
|
562
GitLab
GTLB
$5.57B
| $2.56M | 0.02% |
54,363
+17,363
| +47% | +$1.06M |
|
563
Dollar General
DG
$27.8B
| $2.55M | 0.02% |
+29,000
| New | +$2.2M |
|
|
SRDX
564
DELISTED
Surmodics
SRDX
| $2.54M | 0.02% |
+83,083
| New | +$2.8M |
|
565
CALL
Coca-Cola
KO
$380B
| $2.54M | 0.02% |
+35,400
| New | +$2.36M |
|
566
Pebblebrook Hotel Trust
PEB
$2.2B
| $2.53M | 0.02% |
250,000
+25,000
| +11% | +$306K |
|
|
EVRI
567
DELISTED
Everi Holdings
EVRI
| $2.53M | 0.02% |
+185,000
| New | +$2.53M |
|
568
PUT
Freeport-McMoran
FCX
$88.6B
| $2.52M | 0.02% |
66,500
-27,800
| -29% | -$1.06M |
|
569
CALL
Chipotle Mexican Grill
CMG
$43B
| $2.51M | 0.02% |
50,000
-98,300
| -66% | -$5.35M |
|
570
Nu Holdings
NU
$70.9B
| $2.49M | 0.02% |
243,249
+177,090
| +268% | +$2.09M |
|
571
PUT
PepsiCo
PEP
$195B
| $2.49M | 0.02% |
+16,600
| New | +$2.47M |
|
572
Teradyne
TER
$50.2B
| $2.48M | 0.02% |
30,000
-298,378
| -91% | -$33.4M |
|
|
NBIS
573
Nebius Group N.V.
NBIS
$43.1B
| $2.47M | 0.02% |
117,238
-145,151
| -55% | -$4.78M |
|
574
CAVA Group
CAVA
$7.57B
| $2.47M | 0.02% |
28,576
+10,180
| +55% | +$1.1M |
|
575
CALL
CleanSpark
CLSK
$3.46B
| $2.45M | 0.02% |
365,000
+145,000
| +66% | +$1.37M |
|
Similar funds
AS
TI
LMR Partners's Q1 2025 Portfolio in Review
As of Q1 2025, LMR Partners held 1,734 positions worth $10.7B, down 10% from $11.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
LMR Partners withdrew a net $1.77B in Q1 2025, closing 408 positions and reducing 235 holdings. Its most notable exit was Endeavor Group Holdings, Inc., an estimated $204M position sold in full.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, LMR Partners opened a new position in Roper Technologies worth $48.6M.
- LMR Partners's largest Q1 2025 buy was Roper Technologies: 82,349 shares worth $48.6M.
- LMR Partners added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $107M increase.
- LMR Partners's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $469M.
- LMR Partners fully exited Endeavor Group Holdings, Inc. in Q1 2025, selling an estimated $204M.
- LMR Partners's ten largest holdings make up 18% of its $10.7B portfolio in Q1 2025.
- LMR Partners opened 553 new positions and closed 408 in Q1 2025.
- LMR Partners's portfolio value fell 10% quarter-over-quarter to $10.7B.
Based on LMR Partners's 13F filing for Q1 2025, filed 15 May 2025.